The number of confirmed cases of COVID-19 continues to grow in the US. As of April 5, 2020, there are 312,089 confirmed cases of COVID-19 in the US. These numbers may be an underestimation of the true burden of [...]
This update has been written in collaboration with Dr. Brendon Stiles. He is Chair of the Board for the Lung Cancer Research Foundation, a thoracic surgeon at New York-Presbyterian Hospital and an Associate Professor of Cardiothoracic Surgery at Weill [...]
By Maureen Rigney, LICSW Director, Support Initiatives GO2 for Lung Cancer The coronavirus and the resulting covid-19 disease have changed everyone’s daily lives. In this blog, Maureen Rigney, our lead social worker and boredom fighter, shares her thoughts on [...]
As of March 30, 2020, cases of the virus surge in countries around the world. The United States now has the highest number of COVID-19 cases globally. The CDC has issued a travel advisory for the New York tri-state area, [...]
On March 27, 2020, the Food and Drug Administration (FDA) approved Imfinzi (durvalumab) in combination with etoposide and either carboplatin or cisplatin as first line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC). The FDA based their [...]
As cases of the virus surge in countries around the world, with Italy being particularly hard hit, many nations are taking extreme steps to mitigate the outbreak, including whole country lockdowns. Here in the United States, the President declared [...]
The World Health Organization officially declared the COVID-19 outbreak a pandemic on March 11, 2020. As cases of the virus surge in countries around the world, with Italy being particularly hard hit, many nations are taking extreme steps to [...]
Dear Members of the Lung Cancer Community, For the past several weeks, we have been closely monitoring the developments and impact around the increased spread of the coronavirus. We want each member of our community to know that your [...]
By Laurie Fenton-Ambrose, CEO, President, and Co-Founder GO2 for Lung Cancer I share the sad news of the passing of one of GO2 for Lung Cancer’s longstanding Board members, Amory Houghton, Jr. “Amo”, as he was known by family, [...]
As advocacy organizations dedicated to serving the needs of lung cancer patients, all of us are closely monitoring the latest developments related to the outbreak caused by the novel coronavirus, SARS-CoV-2, and the resulting disease, COVID-19. In this update, [...]